Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Operating Expenses | 1,550 | 1,421 | 1,456 | 2,250 | 2,350 |
| Operating Income | -1,550 | -1,421 | -1,456 | -2,250 | -2,350 |
| Interest Expense | 26 | 25 | 24 | 116 | 199 |
| Other Income | -8 | -23 | 55 | -27 | -182 |
| Pre-tax Income | -1,584 | -1,469 | -1,426 | -2,392 | -2,731 |
| Net Income Continuous | -1,584 | -1,469 | -1,426 | -2,392 | -2,731 |
| Net Income | $-1,584 | $-1,469 | $-1,426 | $-2,392 | $-2,731 |
| EPS Basic Total Ops | -6.90 | -6.80 | -5.60 | -11.80 | -14.50 |
| EPS Basic Continuous Ops | -6.92 | -6.80 | -5.61 | -11.85 | -14.49 |
| EPS Diluted Total Ops | -6.90 | -6.80 | -5.60 | -11.80 | -14.50 |
| EPS Diluted Continuous Ops | -6.92 | -6.80 | -5.61 | -11.85 | -14.49 |
| EBITDA(a) | $-1,548 | $-1,419 | $-1,454 | $-2,199 | $-2,290 |